Merrimack Pharmaceuticals Inc.


Analysts Shine Light on Merrimack Pharmaceuticals Inc (MACK) and AEterna Zentaris Inc. (USA) (AEZS)

Merrimack Pharmaceuticals In a research report sent to investors Wednesday, Cowen’s top analyst Eric Schmidt reiterated a Market Perform rating on shares of Merrimack …

Merrimack Pharmaceuticals Inc (MACK) Commences Operating as a New, Refocused Research and Clinical Development Company

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced that it has commenced operating as a new, refocused research and clinical development company in connection with the …

Stock Update (NASDAQ:MACK): Merrimack Pharmaceuticals Inc Stockholders Approve Sale of ONIVYDE and Generic Version of DOXIL to Ipsen

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that, at its Special Meeting of Stockholders held today, its stockholders voted to approve the asset sale with …

Company Update (NASDAQ:MACK): Merrimack Pharmaceuticals Inc Announces 4Q and Full-Year 2016 Results

Merrimack Pharmaceuticals, Inc (NASDAQ:MACK) announced its fourth quarter and full year 2016 financial results for the period ended December 31, 2016. Key Recent …

Cowen Highlights 4 Biotech Stocks Ahead of Earnings: Gilead Sciences, Inc. (GILD), Merrimack Pharmaceuticals Inc (MACK), ACADIA Pharmaceuticals Inc. (ACAD), Exelixis, Inc. (EXEL)

As earnings season rolls to the foreground and key biotech players like Gilead Sciences, Inc. (NASDAQ:GILD), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), ACADIA Pharmaceuticals Inc.

Company Update (NASDAQ:MACK): Merrimack Pharmaceuticals Inc Appoints Dr. Richard Peters as President and CEO

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)  announced that Richard Peters, M.D.

Cowen Top Analyst Weighs In On Merrimack Pharmaceuticals Inc (MACK) Following Cancer Drugs Deal with Ipsen

In a research report released today, Cowen analyst Eric Schmidt reiterated a Market Perform rating on shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), after …

Stock Update (NASDAQ:MACK): Merrimack Pharmaceuticals Inc Shares Rise 13% Following $1 Billion Asset Purchase and Sale Agreement with Ipsen

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced that it has entered into a definitive asset purchase and sale agreement with Ipsen (Euronext: IPN; ADR: IPSEY) …

Stock Update (NASDAQ:MACK): Merrimack Pharmaceuticals Inc Stops the Phase 2 HERMIONE Trial of MM-302 in HER2-Positive Metastatic Breast Cancer Patients

Merrimack Pharmaceuticals Inc(NASDAQ: MACK) announced that, following a recent independent Data and Safety Monitoring Board (DSMB) recommendation and subsequent futility analysis, it has decided …

Merrimack Pharmaceuticals Inc (MACK) Announces 3Q:16 Financial Results; Shares Fall 5%

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced its third quarter 2016 financial results. Merrimack will host a live conference call and webcast today, Wednesday, November …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts